How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group

Andrea Rubboli; Claudio Fresco; Maurizio Paciaroni; Bianca Rocca; Domenico Pecora; Iolanda Enea; Claudio Cuccia; Giuseppe Rocco Salvatore Patti

doi:10.2459/JCM.0000000000001204

How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group

Andrea Rubboli
, Claudio Fresco
, Maurizio Paciaroni
, Bianca Rocca
, Domenico Pecora
, Iolanda Enea
, Claudio Cuccia
, Giuseppe Rocco Salvatore Patti

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

To evaluate the current interpretation of the lower doses of direct oral anticoagulants (DOAC) dabigatran, apixaban, edoxaban and rivaroxaban in nonvalvular atrial fibrillation.

Original language	English
Journal	Journal of Cardiovascular Medicine
Volume	Publish Ahead of Print
DOIs	https://doi.org/10.2459/JCM.0000000000001204
Publication status	Published - 2021

Access to Document

10.2459/JCM.0000000000001204

http://hdl.handle.net/11579/126011

Cite this

Rubboli, A., Fresco, C., Paciaroni, M., Rocca, B., Pecora, D., Enea, I., Cuccia, C., & Patti, G. R. S. (2021). How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group. Journal of Cardiovascular Medicine, Publish Ahead of Print. https://doi.org/10.2459/JCM.0000000000001204

@article{5daf538aa9e54636bf83f42618dfaa7f,

title = "How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group",

abstract = "To evaluate the current interpretation of the lower doses of direct oral anticoagulants (DOAC) dabigatran, apixaban, edoxaban and rivaroxaban in nonvalvular atrial fibrillation.",

author = "Andrea Rubboli and Claudio Fresco and Maurizio Paciaroni and Bianca Rocca and Domenico Pecora and Iolanda Enea and Claudio Cuccia and Patti, \{Giuseppe Rocco Salvatore\}",

year = "2021",

doi = "10.2459/JCM.0000000000001204",

language = "English",

volume = "Publish Ahead of Print",

journal = "Journal of Cardiovascular Medicine",

issn = "1558-2027",

publisher = "Lippincott Williams and Wilkins",

}

Rubboli, A, Fresco, C, Paciaroni, M, Rocca, B, Pecora, D, Enea, I, Cuccia, C & Patti, GRS 2021, 'How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group', Journal of Cardiovascular Medicine, vol. Publish Ahead of Print. https://doi.org/10.2459/JCM.0000000000001204

How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group. / Rubboli, Andrea; Fresco, Claudio; Paciaroni, Maurizio et al.
In: Journal of Cardiovascular Medicine, Vol. Publish Ahead of Print, 2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group

AU - Rubboli, Andrea

AU - Fresco, Claudio

AU - Paciaroni, Maurizio

AU - Rocca, Bianca

AU - Pecora, Domenico

AU - Enea, Iolanda

AU - Cuccia, Claudio

AU - Patti, Giuseppe Rocco Salvatore

PY - 2021

Y1 - 2021

N2 - To evaluate the current interpretation of the lower doses of direct oral anticoagulants (DOAC) dabigatran, apixaban, edoxaban and rivaroxaban in nonvalvular atrial fibrillation.

AB - To evaluate the current interpretation of the lower doses of direct oral anticoagulants (DOAC) dabigatran, apixaban, edoxaban and rivaroxaban in nonvalvular atrial fibrillation.

UR - https://iris.uniupo.it/handle/11579/126011

U2 - 10.2459/JCM.0000000000001204

DO - 10.2459/JCM.0000000000001204

M3 - Article

SN - 1558-2027

VL - Publish Ahead of Print

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

ER -

How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group

Abstract

Access to Document

Other files and links

Fingerprint

Cite this